{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:19:47Z","timestamp":1783635587783,"version":"3.55.0"},"publisher-location":"New York, NY","reference-count":29,"publisher":"Springer US","isbn-type":[{"value":"9781071650493","type":"print"},{"value":"9781071650509","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5050-9_14","type":"book-chapter","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:02:17Z","timestamp":1783634537000},"page":"171-181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Small Cell Lung Cancer: Screening of Kinase Inhibitors"],"prefix":"10.1007","author":[{"given":"Hamilton","family":"Gerhard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Therese","family":"Eggerstorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Stickler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"4","key":"14_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ctrv.2007.01.006","volume":"33","author":"B Fischer","year":"2000","unstructured":"Fischer B, Marinov M, Arcaro A (2000) Targeting receptor tyrosine kinase signalling in small cell lung cancer (SCLC): what have we learned so far? Cancer Treat Rev 33(4):391\u2013406","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"14_CR2","doi-asserted-by":"publisher","first-page":"6291","DOI":"10.21037\/jtd.2020.03.79","volume":"12","author":"AK Gergen","year":"2020","unstructured":"Gergen AK, Scott CD, Mitchell JD (2020) Surgery for limited stage small cell lung cancer. J Thorac Dis 12(10):6291\u20136297","journal-title":"J Thorac Dis"},{"issue":"3","key":"14_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4103\/atm.ATM_276_16","volume":"12","author":"IS Milovanovic","year":"2017","unstructured":"Milovanovic IS, Stjepanovic M, Mitrovic D (2017) Distribution patterns of the metastases of the lung carcinoma in relation to histological type of the primary tumor: an autopsy study. Ann Thorac Med 12(3):191\u2013198","journal-title":"Ann Thorac Med"},{"issue":"3","key":"14_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/cancers10030063","volume":"10","author":"J Cicenas","year":"2018","unstructured":"Cicenas J, Zalyte E, Bairoch A, Gaudet P (2018) Kinases and cancer. Cancers (Basel) 10(3):63","journal-title":"Cancers (Basel)"},{"issue":"12","key":"14_CR5","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.jtho.2021.07.018","volume":"16","author":"BH Herzog","year":"2021","unstructured":"Herzog BH, Devarakonda S, Govindan R (2021) Overcoming chemotherapy resistance in SCLC. J Thorac Oncol 16(12):2002\u20132015","journal-title":"J Thorac Oncol"},{"issue":"20","key":"14_CR6","doi-asserted-by":"publisher","first-page":"6239","DOI":"10.1158\/1078-0432.CCR-17-1284","volume":"23","author":"T Sen","year":"2017","unstructured":"Sen T, Tong P, Diao L et al (2017) Targeting AXL and mTOR pathway overcomes primary and acquired resistance to WEE1 inhibition in small-cell lung cancer. Clin Cancer Res 23(20):6239\u20136253","journal-title":"Clin Cancer Res"},{"issue":"5","key":"14_CR7","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3390\/cancers16050963","volume":"16","author":"A Tiwari","year":"2024","unstructured":"Tiwari A, Kumari B, Nandagopal S et al (2024) Promises of protein kinase inhibitors in recalcitrant small-cell lung cancer: recent scenario and future possibilities. Cancers (Basel) 16(5):963","journal-title":"Cancers (Basel)"},{"issue":"11","key":"14_CR8","first-page":"3089","volume":"52","author":"L Damstrup","year":"1992","unstructured":"Damstrup L, Rygaard K, Spang-Thomsen M, Poulsen HS (1992) Expression of the epidermal growth factor receptor in human small cell lung cancer cell lines. Cancer Res 52(11):3089\u20133093","journal-title":"Cancer Res"},{"issue":"5","key":"14_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/bjc.1998.553","volume":"78","author":"L Damstrup","year":"1998","unstructured":"Damstrup L, Rude Voldborg B, Spang-Thomsen M, Br\u00fcnner N, Skovgaard Poulsen H (1998) In vitro invasion of small-cell lung cancer cell lines correlates with expression of epidermal growth factor receptor. Br J Cancer 78(5):631\u2013640","journal-title":"Br J Cancer"},{"issue":"2","key":"14_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cytogfr.2005.01.001","volume":"16","author":"VP Eswarakumar","year":"2005","unstructured":"Eswarakumar VP, Lax I, Schlessinger J (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16(2):139\u2013149","journal-title":"Cytokine Growth Factor Rev"},{"issue":"22","key":"14_CR11","first-page":"5239","volume":"58","author":"SM Moore","year":"1998","unstructured":"Moore SM, Rintoul RC, Walker TR, Chilvers ER, Haslett C, Sethi T (1998) The presence of a constitutively active phosphoinositide 3-kinase in small cell lung cancer cells mediates anchorage-independent proliferation via a protein kinase B and p70s6k-dependent pathway. Cancer Res 58(22):5239\u20135247","journal-title":"Cancer Res"},{"issue":"1","key":"14_CR12","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1172\/JCI113594","volume":"82","author":"Y Nakanishi","year":"1988","unstructured":"Nakanishi Y, Mulshine JL, Kasprzyk PG et al (1988) Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. J Clin Invest 82(1):354\u2013359","journal-title":"J Clin Invest"},{"issue":"8","key":"14_CR13","first-page":"2511","volume":"50","author":"VM Macaulay","year":"1990","unstructured":"Macaulay VM, Everard MJ, Teale JD et al (1990) Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells. Cancer Res 50(8):2511\u20132517","journal-title":"Cancer Res"},{"issue":"1","key":"14_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/bjc.1993.7","volume":"67","author":"K Rygaard","year":"1993","unstructured":"Rygaard K, Nakamura T, Spang-Thomsen M (1993) Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor\/scatter factor and stem cell factor, in SCLC cell lines and xenografts. Br J Cancer 67(1):37\u201346","journal-title":"Br J Cancer"},{"issue":"2","key":"14_CR15","first-page":"620","volume":"8","author":"G Maulik","year":"2022","unstructured":"Maulik G, Kijima T, Ma PC et al (2022) Modulation of the c-Met\/hepatocyte growth factor pathway in small cell lung cancer. Clin Cancer Res 8(2):620\u2013627","journal-title":"Clin Cancer Res"},{"issue":"4","key":"14_CR16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1582-4934.2002.tb00453.x","volume":"6","author":"G Maulik","year":"2002","unstructured":"Maulik G, Madhiwala P, Brooks S et al (2002) Activated c-Met signals through PI3K with dramatic effects on cytoskeletal functions in small cell lung cancer. J Cell Mol Med 6(4):539\u2013553","journal-title":"J Cell Mol Med"},{"issue":"2","key":"14_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bcp.2013.09.014","volume":"87","author":"BA Teicher","year":"2014","unstructured":"Teicher BA (2014) Targets in small cell lung cancer. Biochem Pharmacol 87(2):211\u2013219","journal-title":"Biochem Pharmacol"},{"issue":"42","key":"14_CR18","doi-asserted-by":"publisher","first-page":"17034","DOI":"10.1073\/pnas.1207310109","volume":"109","author":"ML Sos","year":"2012","unstructured":"Sos ML, Dietlein F, Peifer M et al (2012) A framework for identification of actionable cancer genome dependencies in small cell lung cancer. Proc Natl Acad Sci USA 109(42):17034\u201317039","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"14_CR19","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/sj.onc.1209117","volume":"25","author":"UK Khanzada","year":"2006","unstructured":"Khanzada UK, Pardo OE, Meier C, Downward J, Seckl MJ, Arcaro A (2006) Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling. Oncogene 25(6):877\u2013887","journal-title":"Oncogene"},{"issue":"9","key":"14_CR20","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/jnci\/dji112","volume":"97","author":"F Cappuzzo","year":"2005","unstructured":"Cappuzzo F, Hirsch FR, Rossi E et al (2005) Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer. J Natl Cancer Inst 97(9):643\u2013655","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"14_CR21","first-page":"1036","volume":"145","author":"JM Ben-Ezra","year":"1994","unstructured":"Ben-Ezra JM, Kornstein MJ, Grimes MM, Krystal G (1994) Small cell carcinomas of the lung express the Bcl-2 protein. Am J Pathol 145(5):1036\u20131040","journal-title":"Am J Pathol"},{"issue":"1","key":"14_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05562-z","volume":"7","author":"L Klameth","year":"2017","unstructured":"Klameth L, Rath B, Hochmaier M et al (2017) Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance. Sci Rep 7(1):5337","journal-title":"Sci Rep"},{"issue":"8","key":"14_CR23","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/17476348.2024.2388288","volume":"18","author":"G Hamilton","year":"2024","unstructured":"Hamilton G, Hochmair MJ, Stickler S (2024) Overcoming resistance in small-cell lung cancer. Expert Rev Respir Med 18(8):569\u2013580","journal-title":"Expert Rev Respir Med"},{"key":"14_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2018.08.007","volume":"436","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wu L, Yao Y, Lu G, Xu L, Zhou J (2018) Polo-like kinase 1 inhibitor BI 6727 induces DNA damage and exerts strong antitumor activity in small cell lung cancer. Cancer Lett 436:1\u20139","journal-title":"Cancer Lett"},{"issue":"3","key":"14_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S1535-6108(04)00051-0","volume":"5","author":"C Garc\u00eda-Echeverr\u00eda","year":"2004","unstructured":"Garc\u00eda-Echeverr\u00eda C, Pearson MA, Marti A et al (2004) In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase. Cancer Cell 5(3):231\u2013239","journal-title":"Cancer Cell"},{"issue":"2","key":"14_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.bcp.2009.08.011","volume":"79","author":"M Li","year":"2010","unstructured":"Li M, Jung A, Ganswindt U et al (2010) Aurora kinase inhibitor ZM447439 induces apoptosis via mitochondrial pathways. Biochem Pharmacol 79(2):122\u2013129","journal-title":"Biochem Pharmacol"},{"key":"14_CR27","doi-asserted-by":"publisher","first-page":"1026020","DOI":"10.3389\/fonc.2022.1026020","volume":"12","author":"A Stefani","year":"2022","unstructured":"Stefani A, Piro G, Schietroma F et al (2022) Unweaving the mitotic spindle: a focus on Aurora kinase inhibitors in lung cancer. Front Oncol 12:1026020","journal-title":"Front Oncol"},{"issue":"4","key":"14_CR28","doi-asserted-by":"publisher","first-page":"e3253","DOI":"10.1002\/btpr.3253","volume":"38","author":"L van der Merwe","year":"2022","unstructured":"van der Merwe L, Svitina H, Willers C, Wrzesinski K, Gouws C (2022) A novel NCI-H69V small cell lung cancer functional mini-tumor model for future treatment screening applications. Biotechnol Prog 38(4):e3253","journal-title":"Biotechnol Prog"},{"key":"14_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/978-1-0716-4003-6_14","volume":"2834","author":"A Gambacurta","year":"2025","unstructured":"Gambacurta A, Tullio V, Savini I, Catani MV, Gasperi V (2025) In vitro cell-based MTT and crystal violet assays for drug toxicity screening. Methods Mol Biol 2834:293\u2013301","journal-title":"Methods Mol Biol"}],"container-title":["Methods in Molecular Biology","Circulating Tumor Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5050-9_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:02:19Z","timestamp":1783634539000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5050-9_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071650493","9781071650509"],"references-count":29,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5050-9_14","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"3 June 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}